Preventative effects of ginkgo biloba extract (EGb761) on high glucose-cultured opacity of rat lens

Phytotherapy Research

Volumn 28, Issue 5, 2014, Pages 767-773

  Lu, Qian ^a,b   Yang, Tingting ^b   Zhang, Mingzhu ^b   Du, Lei ^b   Liu, Ling ^b   Zhang, Nan ^b   Guo, Hao ^b   Zhang, Fan ^b   Hu, Gang ^a   Yin, Xiaoxing ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ginkgo biloba extract; high glucose; lens opacity; oxidative stress; TGF 2

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; ALPHA SMOOTH MUSCLE ACTIN; BENDAZAC LYSINE; GINKGO BILOBA EXTRACT; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UVOMORULIN;

ALPHA SMA GENE; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; E CADHERIN GENE; ENZYME ACTIVATION; ENZYME ACTIVITY; EYE PROTECTION; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TGF BETA2 GENE;

GINKGO BILOBA; RATTUS;

GINKGO BILOBA EXTRACT; HIGH GLUCOSE; LENS OPACITY; OXIDATIVE STRESS; TGF-Β2;

ALDEHYDE REDUCTASE; ANIMALS; CATARACT; CULTURE MEDIA; DIABETES COMPLICATIONS; FEMALE; GINKGO BILOBA; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; LENS, CRYSTALLINE; MALE; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899483782     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5060     Document Type: Article

References (27)

1. Ahmed N,. 2005. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21.
2. Brownlee M,. 2005. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54: 1615-1625.
3. Blownlee M, Vlassara H, Cerami A,. 1985. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes 34: 938-941.
4. Chamberlain CG, Mansfield KJ, Cerra A,. 2009. Glutathione and catalase suppress TGFbeta-induced cataract-related changes in cultured rat lenses and lens epithelial explants. Mol Vis 15: 895-905.
5. Cho HJ, Yoo J,. 2007. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 31: 1225-1230.
6. de Iongh RU, Wederell E, Lovicu FJ, et al,. 2005. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs 179: 43-55.
7. Hashim Z, Zarina S,. 2011. Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract. Age (Dordr) 33: 377-384.
8. Ji L, Yin XX, Wu ZM, et al,. 2009. Ginkgo biloba extract prevents glucose-induced accumulation of ECM in rat mesangial cells. Phytother Res 23: 477-485.
9. Kim NH, Kim YS, Jung DH, et al,. 2010. Kiom-79 prevents xylose-induced lens opacity and inhibits TGF-beta2 in human lens epithelial cells cultured under high glucose. J Ethnopharmacol 130: 599-606.
10. Kojima M, Sun L, Hata I, et al,. 2007. Efficacy of alpha-lipoic acid against diabetic cataract in rat. Jpn J Ophthalmol 51: 10-13.
11. Kubo E, Miyoshi N, Fukuda M, et al,. 1999. Cataract formation through the polyol pathway is associated with free radical production. Exp Eye Res 68: 457-464.
12. Lee AY, Chung SS,. 1999. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 13: 23-30.
13. Liu L, Lu Q, Yang TT, et al,. 2012. Preventive effects of ginkgo biloba extract on rat diabetic cataract. Chinese Pharmacol Bull 28: 1709-1713.
14. Lovicu FJ, Ang S, Chorazyczewska M, et al,. 2004. Deregulation of lens epithelial cell proliferation and differentiation during the development of TGFbeta-induced anterior subcapsular cataract. Dev Neurosci 26: 446-455.
15. Lu Q, Yin XX, Wang JY, et al,. 2007. Effects of ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol Sin 28: 818-828.
16. Lu Q, Zhai Y, Cheng Q, et al,. 2013. The Akt-FoxO3a-manganese superoxide dismutase pathway is involved in the regulation of oxidative stress in diabetic nephropathy. Exp Physiol 98: 934-945.
17. MacDonald E, Lee WK, Hepburn S, et al,. 1992. Advanced glycosylation end products in the mesenteric artery. Clin Chem 38: 530-3.
18. Obrosova IG, Chung SS, Kador PF,. 2010. Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev 26: 172-180.
19. Olofsson EM, Marklund SL, Karlsson K, et al,. 2005. In vitro glucose-induced cataract in copper-zinc superoxide dismutase null mice. Exp Eye Res 81: 639-46.
20. Pollreisz A, Schmidt-Erfurth U,. 2010. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol 2010: 608751.
21. Saraswat M, Suryanarayana P, Reddy PY, et al,. 2010. Antiglycating potential of zingiber officinalis and delay of diabetic cataract in rats. Mol Vis 16: 1525-1537.
22. Seo HG, Nishinaka T, Yabe-Nishimura C,. 2000. Nitric oxide up-regulates aldose Reductase expression in rat vascular smooth muscle cells: a potential role for aldose Reductase in vascular remodeling. Mol Pharmacol 57: 709-17.
23. Srivastava SK, Ramana KV, Bhatnagar A,. 2005. Role of aldose Reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26: 380-392.
24. Wang JY, Yin XX, Wu YM, et al,. 2006. Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells. Acta Pharmacol Sin 27: 1222-1230.
25. Williams DL, Munday P,. 2006. The effect of a topical antioxidant formulation including N-acetyl carnosine on canine cataract: a preliminary study. Vet Ophthalmol 9: 311-316.
26. Wu ZM, Yin XX, Ji L, et al,. 2008. Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells. Acta Pharmacol Sin 29: 1042-1050.
27. Zhang S, Chai FY, Yan H, et al,. 2008. Effects of N-acetylcysteine and glutathione ethyl ester drops on Streptozotocin-induced diabetic cataract in rats. Mol Vis 14: 862-870.